122 related articles for article (PubMed ID: 6471070)
1. Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives.
Auclair C; Voisin E; Banoun H; Paoletti C; Bernadou J; Meunier B
J Med Chem; 1984 Sep; 27(9):1161-6. PubMed ID: 6471070
[TBL] [Abstract][Full Text] [Related]
2. Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
Auclair C; Pierre A; Voisin E; Pepin O; Cros S; Colas C; Saucier JM; Verschuere B; Gros P; Paoletti C
Cancer Res; 1987 Dec; 47(23):6254-61. PubMed ID: 3677074
[TBL] [Abstract][Full Text] [Related]
3. Accessibility to bacterial nucleic acids of the intercalating drug aliphatic amino acid ellipticinium derivatives in Escherichia coli and Salmonella typhimurium.
Banoun H; Le Bret M; Auclair C
Biochemistry; 1985 Jan; 24(3):701-7. PubMed ID: 3888261
[TBL] [Abstract][Full Text] [Related]
4. Peroxidase-catalyzed covalent binding of the antitumor drug N2-methyl-9-hydroxyellipticinium to DNA in vitro.
Auclair C; Dugué B; Meunier B; Paoletti C
Biochemistry; 1986 Mar; 25(6):1240-5. PubMed ID: 3964674
[TBL] [Abstract][Full Text] [Related]
5. Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cells.
Larsen AK; Paoletti J; Belehradek J; Paoletti C
Cancer Res; 1986 Oct; 46(10):5236-40. PubMed ID: 3756875
[TBL] [Abstract][Full Text] [Related]
6. A new series of ellipticine derivatives (1-(alkylamino)-9-methoxyellipticine). Synthesis, DNA binding, and biological properties.
Larue L; Rivalle C; Muzard G; Paoletti C; Bisagni E; Paoletti J
J Med Chem; 1988 Oct; 31(10):1951-6. PubMed ID: 3172128
[TBL] [Abstract][Full Text] [Related]
7. Basically substituted ellipticine analogues as potential antitumor agents.
Werbel LM; Angelo M; Fry DW; Worth DF
J Med Chem; 1986 Jul; 29(7):1321-2. PubMed ID: 3806584
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives.
Ducrocq C; Wendling F; Tourbez-Perrin M; Rivalle C; Tambourin P; Pochon F; Bisagni E; Chermann JC
J Med Chem; 1980 Nov; 23(11):1212-6. PubMed ID: 7452670
[TBL] [Abstract][Full Text] [Related]
9. Syntheses and in vitro evaluation of water-soluble "cationic metalloporphyrin-ellipticine" molecules having a high affinity for DNA.
Ding L; Etemad-Moghadam G; Cros S; Auclair C; Meunier B
J Med Chem; 1991 Mar; 34(3):900-6. PubMed ID: 2002470
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 11H-pyridocarbazoles and derivatives. Comparison of their DNA binding and antitumor activity with those of 6H- and 7H-pyridocarbazoles.
Lescot E; Muzard G; Markovits J; Belleney J; Roques BP; Le Pecq JB
J Med Chem; 1986 Sep; 29(9):1731-7. PubMed ID: 3746819
[TBL] [Abstract][Full Text] [Related]
11. [Syntheses designed to produce 8-amino ellipticine. Synthesis and pharmacological properties of 8-nitro ellipticine].
Gansser C; Lévque X; Plat M; Viel C
Farmaco Sci; 1982 May; 37(5):283-97. PubMed ID: 7095141
[TBL] [Abstract][Full Text] [Related]
12. Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates.
Rigaudy P; Charcosset JY; Garbay-Jaureguiberry C; Jacquemin-Sablon A; Roques BP
Cancer Res; 1989 Apr; 49(7):1836-42. PubMed ID: 2538235
[TBL] [Abstract][Full Text] [Related]
13. 1-Amino-substituted 4-methyl-5H-pyrido[4,3-b]indoles (gamma-carbolines) as tricyclic analogues of ellipticines: a new class of antineoplastic agents.
Bisagni E; Nguyen CH; Pierré A; Pépin O; de Cointet P; Gros P
J Med Chem; 1988 Feb; 31(2):398-405. PubMed ID: 3339609
[TBL] [Abstract][Full Text] [Related]
14. Some antitumor derivatives of ellipticine deprived of mutagenic properties.
Lecointe P; Lesca P; Cros S; Paoletti C
Chem Biol Interact; 1978 Jan; 20(1):113-21. PubMed ID: 630641
[TBL] [Abstract][Full Text] [Related]
15. Use of a new DNA intercalating fluorescing probe for studies on the mechanism of frameshift mutagenesis in Salmonella typhimurium.
René B; Banoun H; Auclair C; Paoletti C
Biochimie; 1985; 67(3-4):327-34. PubMed ID: 3899187
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective synthesis of 9-hydroxyellipticine glycosides, novel and highly active antitumor agents.
Honda T; Inoue M; Kato M; Shima K; Shimamoto T
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3975-8. PubMed ID: 3435996
[No Abstract] [Full Text] [Related]
17. Interaction between 2N-methyl-9-hydroxyellipticinium and ionizing radiation in CHO cells.
Laval F
Int J Radiat Biol; 1993 Aug; 64(2):217-23. PubMed ID: 8103546
[TBL] [Abstract][Full Text] [Related]
18. Interrelationship between affinity for DNA, cytotoxicity and induction of DNA-breaks in cultured L1210 cells for two series of tricyclic intercalators. Simplified analogues of ellipticine derivatives.
Pierson V; Pierre A; de Cointet P; Nguyen CH; Bisagni E; Gros P
Biochem Pharmacol; 1989 May; 38(9):1395-406. PubMed ID: 2719718
[TBL] [Abstract][Full Text] [Related]
19. DNA intercalating compounds as potential antitumor agents. 1. Preparation and properties of 7H-pyridocarbazoles.
Pelaprat D; Oberlin R; Le Guen I; Roques BP; Le Pecq JB
J Med Chem; 1980 Dec; 23(12):1330-5. PubMed ID: 7452685
[TBL] [Abstract][Full Text] [Related]
20. Drug-DNA interactions: spectroscopic and footprinting studies of site and sequence specificity of elliptinium.
Mauffret O; Rene B; Convert O; Monnot M; Lescot E; Fermandjian S
Biopolymers; 1991 Oct; 31(11):1325-41. PubMed ID: 1777583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
